These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38486811)

  • 21. Distribution of legal retail cannabis stores in Canada by neighbourhood deprivation.
    Fataar F; Driezen P; Owusu-Bempah A; Hammond D
    J Cannabis Res; 2024 Feb; 6(1):5. PubMed ID: 38351142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Policies regulating retail environment to reduce tobacco availability: A scoping review.
    Alebshehy R; Asif Z; Boeckmann M
    Front Public Health; 2023; 11():975065. PubMed ID: 36866095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recreational Marijuana Legalization, Local Retail Availability, and Alcohol and Marijuana Use and Co-Use Among California High School Students.
    O'Hara SE; Paschall MJ; Grube JW
    J Stud Alcohol Drugs; 2023 Sep; 84(5):734-743. PubMed ID: 37219033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proximity to Legal Cannabis Stores in Canada and Use of Cannabis Sources in the First Three Years of Legalization, 2019-2021.
    Wadsworth E; Driezen P; Dilley JA; Gabrys R; Jesseman R; Hammond D
    J Stud Alcohol Drugs; 2023 Nov; 84(6):852-862. PubMed ID: 37306374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis legalisation: should doctors be concerned?
    Kanniah G; Kumar S
    N Z Med J; 2021 Jun; 134(1537):84-90. PubMed ID: 34239164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between non-medical cannabis legalization and emergency department visits for cannabis-induced psychosis.
    Myran DT; Pugliese M; Roberts RL; Solmi M; Perlman CM; Fiedorowicz J; Tanuseputro P; Anderson KK
    Mol Psychiatry; 2023 Oct; 28(10):4251-4260. PubMed ID: 37500826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of State Cannabis Laws and Rates of Self-harm and Assault.
    Matthay EC; Kiang MV; Elser H; Schmidt L; Humphreys K
    JAMA Netw Open; 2021 Mar; 4(3):e211955. PubMed ID: 33734416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kratom Retail Availability in Fort Worth, Texas.
    LoParco CR; Yockey RA; Sekhon VK; Olsson S; Galindo R; Balasundaram R; Agwuncha T; Rossheim ME
    J Psychoactive Drugs; 2024; 56(1):8-13. PubMed ID: 36841785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does liberalisation of cannabis policy influence levels of use in adolescents and young adults? A systematic review and meta-analysis.
    Melchior M; Nakamura A; Bolze C; Hausfater F; El Khoury F; Mary-Krause M; Azevedo Da Silva M
    BMJ Open; 2019 Jul; 9(7):e025880. PubMed ID: 31296507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabis Retail Market Indicators in Five Legal States in the United States: A Public Health Perspective.
    Dilley JA; Johnson JK; Colby AM; Sheehy TJ; Muse EJ; Filley JR; Segawa MB; Schauer GL; Kilmer B
    Clin Ther; 2023 Aug; 45(8):778-786. PubMed ID: 37455228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and outcomes of prenatal recreational cannabis use in high-income countries: a scoping review.
    Singh S; Filion KB; Abenhaim HA; Eisenberg MJ
    BJOG; 2020 Jan; 127(1):8-16. PubMed ID: 31529594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retail Availability of Recreational Marijuana and Alcohol in Oregon Counties and Co-Use of Alcohol and Marijuana and Related Beliefs among Adolescents.
    García-Ramírez G; Paschall MJ; Grube JW
    Subst Use Misuse; 2021; 56(3):345-352. PubMed ID: 33435786
    [No Abstract]   [Full Text] [Related]  

  • 33. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.
    Hall W; Stjepanović D; Caulkins J; Lynskey M; Leung J; Campbell G; Degenhardt L
    Lancet; 2019 Oct; 394(10208):1580-1590. PubMed ID: 31657733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the legalisation of recreational cannabis use.
    Isorna M; Pascual F; Aso E; Arias F
    Adicciones; 2023 Sep; 35(3):349-376. PubMed ID: 35472157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Legal cannabis market shares during Canada's first year of recreational legalisation.
    Armstrong MJ
    Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019.
    Callaghan RC; Sanches M; Vander Heiden J; Kish SJ
    Drug Alcohol Rev; 2023 Jul; 42(5):1104-1113. PubMed ID: 36908258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental interventions to reduce the consumption of sugar-sweetened beverages and their effects on health.
    von Philipsborn P; Stratil JM; Burns J; Busert LK; Pfadenhauer LM; Polus S; Holzapfel C; Hauner H; Rehfuess E
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012292. PubMed ID: 31194900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Cannabis-Attributable Hospitalizations Following Nonmedical Cannabis Legalization in Canada.
    Myran DT; Gaudreault A; Konikoff L; Talarico R; Liccardo Pacula R
    JAMA Netw Open; 2023 Oct; 6(10):e2336113. PubMed ID: 37796504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic Pain, Cannabis Legalization and Cannabis Use Disorder in Veterans Health Administration Patients, 2005 to 2019.
    Hasin DS; Wall MM; Alschuler D; Mannes ZL; Malte C; Olfson M; Keyes KM; Gradus JL; Cerdá M; Maynard CC; Keyhani S; Martins SS; Fink DS; Livne O; McDowell Y; Sherman S; Saxon AJ
    medRxiv; 2023 Jul; ():. PubMed ID: 37503049
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.